Market Research Report

A quick peek into the report

Global Oncolytic Virus Therapies Market

Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

Some Faq's

Frequently Asked Questions

The global oncolytic virus therapies market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030 and reach a market value of $962 million by 2030. 

Several factors such as the increasing incidence of cancer, rising number of clinical trials, increasing research funding from National Cancer Institute, and increasing adoption of inorganic growth strategies in the market, favour the growth of this emerging tech. 

High cost of therapy and lack of therapy-specific-assays may cause hindrance in the adoption of oncolytic virus therapies globally. 

In 2020, the North American region held the largest share in the global market for oncolytic virus therapies owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. 

The major market share holders in the oncolytic virus therapies industry include DNAtrix, Daiichi Sankyo Company Ltd., Takara Bio Inc., Sorrento Therapeutics Inc., ViroCure, Shanghai Sunway Biotech Co. Ltd., and VCN Biosciences, among others. 

Similar Product

You may also like

Global PD-1/PD-L1 Immunotherapy Market
Published Year: 2020

Global PD-1/PD-L1 Immunotherapy Market: Focus on Type, Application, Country Data (14 Countries), and

The global market for PD-1/PD-L1 immunotherapy is predicted to grow at a CAGR of 10.72% over...

Global Cancer Immunotherapy Market
Published Year: 2019

Global Cancer Immunotherapy Market: Focus on Pharmaceutical Products, Therapeutic Indication, Compet

The global cancer immunotherapy market was valued at $39.86 billion in 2017 and is anticipated...